These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34886680)

  • 1. Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical Trial.
    Marquis-Gravel G; Hammill BG; Mulder H; Roe MT; Robertson HR; Wruck LM; Sharlow A; Harris DF; Pohlman FW; Hernandez AF; Jones WS
    Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e008190. PubMed ID: 34886680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health.
    Ma Q; Chung H; Shambhu S; Roe M; Cziraky M; Jones WS; Haynes K
    Clin Trials; 2019 Aug; 16(4):419-430. PubMed ID: 31081367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.
    Marquis-Gravel G; Roe MT; Robertson HR; Harrington RA; Pencina MJ; Berdan LG; Hammill BG; Faulkner M; Muñoz D; Fonarow GC; Nallamothu BK; Fintel DJ; Ford DE; Zhou L; Daugherty SE; Nauman E; Kraschnewski J; Ahmad FS; Benziger CP; Haynes K; Merritt JG; Metkus T; Kripalani S; Gupta K; Shah RC; McClay JC; Re RN; Geary C; Lampert BC; Bradley SM; Jain SK; Seifein H; Whittle J; Roger VL; Effron MB; Alvarado G; Goldberg YH; VanWormer JL; Girotra S; Farrehi P; McTigue KM; Rothman R; Hernandez AF; Jones WS
    JAMA Cardiol; 2020 May; 5(5):598-607. PubMed ID: 32186653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance Between Patient-Reported Health Data and Electronic Health Data in the ADAPTABLE Trial.
    O'Brien EC; Mulder H; Jones WS; Hammill BG; Sharlow A; Hernandez AF; Curtis LH
    JAMA Cardiol; 2022 Dec; 7(12):1235-1243. PubMed ID: 36322059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study.
    Faridi KF; Tamez H; Butala NM; Song Y; Shen C; Secemsky EA; Mauri L; Curtis JP; Strom JB; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e006589. PubMed ID: 33435731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study.
    Weissler EH; Stebbins A; Wruck L; Muñoz D; Gupta K; Girotra S; Whittle J; Benziger CP; Polonsky TS; Bradley SM; Hammill BG; Merritt JG; Zemon DN; Hernandez AF; Jones WS
    Vasc Med; 2023 Apr; 28(2):122-130. PubMed ID: 37025023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
    Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
    JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.
    Easton JD; Denison H; Evans SR; Knutsson M; Amarenco P; Albers GW; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KL; Johnston SC;
    Int J Stroke; 2019 Dec; 14(9):908-914. PubMed ID: 31092152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.
    Ahmad FS; Ricket IM; Hammill BG; Eskenazi L; Robertson HR; Curtis LH; Dobi CD; Girotra S; Haynes K; Kizer JR; Kripalani S; Roe MT; Roumie CL; Waitman R; Jones WS; Weiner MG
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006292. PubMed ID: 32466729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events.
    Teramoto T; Shimada K; Uchiyama S; Sugawara M; Goto Y; Yamada N; Oikawa S; Ando K; Ishizuka N; Yamazaki T; Yokoyama K; Murata M; Ikeda Y
    Am Heart J; 2010 Mar; 159(3):361-369.e4. PubMed ID: 20211296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial.
    Matías-Guiu J; Ferro JM; Alvarez-Sabín J; Torres F; Jiménez MD; Lago A; Melo T;
    Stroke; 2003 Apr; 34(4):840-8. PubMed ID: 12649515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
    Mehran R; Baber U; Sharma SK; Cohen DJ; Angiolillo DJ; Briguori C; Cha JY; Collier T; Dangas G; Dudek D; Džavík V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta SR; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM
    N Engl J Med; 2019 Nov; 381(21):2032-2042. PubMed ID: 31556978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study.
    Guimarães PO; Krishnamoorthy A; Kaltenbach LA; Anstrom KJ; Effron MB; Mark DB; McCollam PL; Davidson-Ray L; Peterson ED; Wang TY
    JAMA Cardiol; 2017 Jul; 2(7):750-757. PubMed ID: 28538984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
    Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
    Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record.
    Chu CD; Lenoir KM; Rai NK; Soman S; Dwyer JP; Rocco MV; Agarwal AK; Beddhu S; Powell JR; Suarez MM; Lash JP; McWilliams A; Whelton PK; Drawz PE; Pajewski NM; Ishani A; Tuot DS
    Contemp Clin Trials; 2023 May; 128():107172. PubMed ID: 37004812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of low-dose aspirin in polycythemia vera.
    Landolfi R; Marchioli R; Kutti J; Gisslinger H; Tognoni G; Patrono C; Barbui T;
    N Engl J Med; 2004 Jan; 350(2):114-24. PubMed ID: 14711910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    McNeil JJ; Wolfe R; Woods RL; Tonkin AM; Donnan GA; Nelson MR; Reid CM; Lockery JE; Kirpach B; Storey E; Shah RC; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Johnston CI; Ryan J; Radziszewska B; Jelinek M; Malik M; Eaton CB; Brauer D; Cloud G; Wood EM; Mahady SE; Satterfield S; Grimm R; Murray AM;
    N Engl J Med; 2018 Oct; 379(16):1509-1518. PubMed ID: 30221597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.